Arecor's Tetris launches 'Ogluo' in Austria
4th Jan 2023 16:01
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced on Wednesday that its subsidiary Tetris Pharma has launched 'Ogluo', or glucagon prefilled autoinjector pens, as a treatment for severe hypoglycaemia in children and adults living with diabetes in Austria.
Read moreArecor inks formulation study deal with 'leading' pharma firm
10th Nov 2022 14:01
(Sharecast News) - Biopharmaceuticals developer Arecor Therapeutics has signed an exclusive formulation study collaboration with the pharmaceutical division of "one of the world's largest" chemicals marketing and pharma companies, it announced on Thursday, which focuses on the development and commercialisation of speciality drugs.
Read moreArecor's Tetris launches hypoglycaemia treatment in Germany
1st Nov 2022 16:41
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced on Tuesday that its subsidiary Tetris Pharma has launched the 'Ogluo' glucagon-prefilled autoinjector pen as a treatment for severe hypoglycaemia in children and adults living with diabetes in Germany.
Read moreArecor gets two EU patents for adalimumab formulations
9th Aug 2022 13:54
(Sharecast News) - Biopharmaceutical developer Arecor Therapeutics has been granted two European patents protecting its novel formulations of high-concentration 'adalimumab' until 2038, it announced on Tuesday.
Read moreExpectations exceeded for Arecor's two lead clinical-stage programmes
23rd May 2022 12:21
(Sharecast News) - Biopharmaceutical developer Arecor Therapeutics said in an update on Monday that it was making "huge strides" on its growth trajectory, focussed on its two lead clinical-stage programmes.
Read moreArecor granted first US patent for insulin formulations
23rd Mar 2022 13:47
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced on Wednesday that the United States Patent and Trademark Office has granted a patent protecting novel formulations of its proprietary insulin products, 'AT247' and 'AT278'.
Read moreArecor flags milestone payment from Hikma in first half of next year
21st Dec 2021 15:55
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.
Read more